Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET

Abstract Background Alterations in the expression of human kallikrein-related peptidases (KLKs) have been described in patients with Alzheimer’s disease (AD). We elucidated the suitability of KLK6, KLK8 and KLK10 to distinguish AD from NC and explored associations with established AD biomarkers. Met...

Description complète

Détails bibliographiques

Auteurs principaux:	Oliver Goldhardt, Inanna Warnhoff, Igor Yakushev, Ilijana Begcevic, Hans Förstl, Viktor Magdolen, Antoninus Soosaipillai, Eleftherios Diamandis, Panagiotis Alexopoulos, Timo Grimmer
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2019-08-01
Collection:	Translational Neurodegeneration
Sujets:	Alzheimer’s disease (AD) Kallikrein-like peptidase (KLK) KLK6 KLK8 KLK10 Cerebral amyloid load
Accès en ligne:	http://link.springer.com/article/10.1186/s40035-019-0168-6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!